仙樂健康(300791.SZ):2019年淨利預降26.19%-36.03%
格隆匯1月23日丨仙樂健康(300791.SZ)披露2019年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為1.3億元-1.5億元,同比下降26.19%-36.03%。
公司本期經營和銷售與去年同期相比保持穩定,但銷售增長未達預期,同時本期營業成本增幅較大,導致歸屬於上市公司股東的淨利潤較去年同期下降,以下主要因素導致公司2019年營業成本增幅較大:
1、募集資金投資項目“安徽馬鞍山生產基地建設項目”——馬鞍山軟糖車間投產,公司的軟糖產品生產陸續由汕頭轉移至馬鞍山,由於產品異地轉移需要經過中試、工藝驗證、客户審計、標準重新備案、產品穩定性考察等環節,生產轉移持續至2019年底。而投產及轉移期間試生產、固定攤銷、管理費用較大,影響了軟糖產品毛利率以及安徽仙樂的利潤水平;同時新的生產設備更強的產品功能也使得公司加大了新品開發方面的投入。隨着轉移的完成和產能的釋放,軟糖產品的毛利率和安徽仙樂的利潤水平將逐步趨於正常狀態。
2、為了提升公司核心競爭力與保障未來的可持續發展,2019年公司在吸引核心人才,拓展業務團隊,引進研發人員等人才梯隊建設方面加大投入,致使當年人力成本增加。
3、公司本期預計非經常損益約為1370萬元,主要為公司收到的政府補助、投資收益等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.